The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The device remains implanted and will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
|
It was reported that a patient death occurred.The patient had metastatic esophageal cancer which had been largely stable for several months, with dominant disease in his liver, which had showed progression.The patient was treated with therasphere on (b)(6) 2021.A moderate right pleural effusion was noted on the post procedure computed tomography (ct).The patient was discharged, however, the patient was admitted on (b)(6) 2021 for shortness of breath, which was assessed as the physician as almost certainly not a side effect of the treatment.The patient had documented pulmonary metastatic disease prior to the treatment and an effusion on the day of treatment, which could not have developed instantly.The effusion caused his shortness of breath, which provoked his presentation to the hospital.A thoracentesis and additional diagnostic imaging was performed.The patient entered hospice care and expired on (b)(6) 2021.The cause of death is progression of disease.
|